微血管侵犯肝细胞癌微创与开腹肝切除倾向评分匹配研究
该单中心倾向评分匹配研究纳入171例合并微血管侵犯(MVI)的肝细胞癌(HCC)患者,比较微创肝切除(MILR,机器人或腹腔镜)与开腹肝切除(OLR)的预后。经1:4倾向评分匹配(PSM)后,两组无复发生存(RFS)和总生存(OS)无显著差异,围术期参数及主要术后并发症发生率相当。结论认为微创入路可为MVI相关HCC提供与开腹相当的长期生存结果。
要点
- MVI是HCC术后复发的主要风险因素之一。
- PSM后MILR与OLR的RFS和OS无显著差异。
- 围术期参数及主要并发症率两组相当。
核心结论
- 对合并MVI的HCC患者,微创入路可提供与传统开腹入路相当的长期生存结果。
研究设计与样本
- 患者分为微创肝切除组(机器人或腹腔镜)和开腹肝切除组,按1:4进行倾向评分匹配以平衡基线特征。
- 比较匹配前后两组的生存参数和围术期参数。
主要发现
- 匹配前后两组无复发生存(RFS)和总生存(OS)均无显著差异。
- 亚组分析显示,在解剖性切除、IWATE难度评分、手术切缘和术后辅助治疗方面,两组OS和RFS均无显著差异。
- 两组围术期参数和主要术后并发症发生率相当。
临床怎么用
- 对于合并MVI的HCC患者,微创肝切除可作为与开腹肝切除相当的术式选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Microvascular invasion (MVI) is one of the major risk factors for postoperative recurrence of HCC. For HCC patients with MVI, few studies have examined the differences in prognosis between minimally invasive and open liver resection. MATERIALS AND METHODS: A total of 171 HCC patients with MVI who underwent curative-intent hepatectomy from September 2017 to October 2022 at Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, were enrolled in this study. Patients were categorized into minimally invasive liver resection (MILR) group (Robotic or laparoscopic) and open liver resection (OLR) group. In order to balance the baseline characteristics between the two groups, 1:4 propensity score matching (PSM) was performed on the two groups. The survival parameters and perioperative parameters were compared between the two groups before and after PSM, respectively. RESULTS: There was no significant difference in Recurrence Free Survival (RFS) and Overall Survival (OS) between the two groups before and after PSM. Subgroup analysis showed that there were no significant differences in OS and RFS between the two groups regarding anatomical resection, IWATE difficulty score, surgical margins, and postoperative adjuvant therapy. Perioperative parameters and the rate of major postoperative complications were comparable between the two groups. CONCLUSION: Minimally invasive approach can provide a comparable long-term survival result compared with conventional open approach for patients with HCC associated with MVI.
引用
- Yang Z, Zhang Y, Zheng J, et al. Minimally invasive versus open liver resection for hepatocellular carcinoma with microvascular invasion: a propensity score-matching study. Surg Endosc. 2025. PMID: 40251314. doi:10.1007/s00464-025-11717-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。